Parliamentary.ai


by Munro Research

Controlled Drugs (Procedure for Specification) Bill


Official Summary

A Bill to change the procedure for amending Schedule 2 to the Misuse of Drugs Act 1971.

Summary powered by AnyModel

Overview

This bill modifies the process for altering Schedule 2 of the Misuse of Drugs Act 1971, which lists controlled substances. The changes aim to enhance parliamentary oversight of adjustments to this crucial schedule.

Description

The bill amends the Misuse of Drugs Act 1971 to change how Schedule 2 (listing controlled drugs) is amended. Currently, the Secretary of State can make changes through Orders in Council. This bill replaces this with a new system:

  • The Secretary of State will amend Schedule 2 using statutory instruments (regulations).
  • Before these regulations can be made, a draft must be laid before and approved by both Houses of Parliament.
  • The Secretary of State must consult with, or act on the recommendation of, the Advisory Council before laying a draft instrument before Parliament.

The bill also makes consequential amendments to other sections of the 1971 Act to ensure consistency with the new procedure. Existing Orders in Council made before the bill's enactment are unaffected.

Government Spending

The bill is not expected to have a significant direct impact on government spending. The costs will be associated with the parliamentary process of reviewing and approving the new regulations, and the administrative costs related to consultations with the Advisory Council. No specific figures are provided in the bill text.

Groups Affected

  • Parliament: Will have increased scrutiny over changes to the list of controlled drugs.
  • The Secretary of State: Will have a modified procedure for updating the list of controlled substances.
  • The Advisory Council: Will be involved in the consultation process for proposed changes to Schedule 2.
  • Law enforcement agencies: Will need to comply with any changes to the list of controlled substances.
  • Individuals and organizations involved in the production, distribution, or use of controlled substances: Their activities will be affected by any changes to the list of controlled drugs.
Full Text

Powered by nyModel

DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.